← All stocks

ABT vs DXCM

Abbott Laboratories Common Stock vs DexCom Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ABT
Abbott Laboratories Common Stock
Healthcare
102.61
177.55B
DXCM
DexCom Inc. Common Stock
Healthcare
89.35
33.72B
ACCE scores
ABT
DXCM
Composite score
Out of 100
48
76
Growth
40
76
Value
55
39
Quality
67
92
Momentum
31
97
Valuation
ABT
DXCM
Price
102.61
89.35
Market cap
177.55B
33.72B
Trailing P/E
33.21
35.32
Forward P/E
16.95
28.74
EV / EBITDA
17.45
21.27
Dividend yield
2.4%
0.0%
Profitability
ABT
DXCM
ROE
10.6%
38.5%
Net margin
11.7%
20.1%
Debt / equity
0.25
0.46
Free cash flow
7.39B
1.08B
Growth
ABT
DXCM
Revenue growth (YoY)
13.0%
13.1%
Earnings growth (YoY)
-47.5%
43.6%
Analyst target
120.26
94.48
See full analysis